Key information

Application number
202015475
Trademark text
BYXLIZO
Case type
National mark
Status
07.12.2020 Uten forutgående uttalelse
Filed
03.12.2020
Registration number
312907
Registered
07.12.2020
Published in the Gazette
14.12.2020
Opposition deadline
14.03.2021
Grace period start date, cf. Trademarks Act Section 37
16.03.2021
Renewal deadline
03.12.2030
Trademark category
Trademark
Type of Mark
Word Mark
Goods/services (NICE class)
5
Acquired distinctiveness
No
Applicant
BeiGene, Ltd. (KY)
Owner
BeiGene, Ltd. (KY)
Agent
BRYN AARFLOT AS (NO)

List of products


Class 5
Medisiner til mennesker; kapsler for farmasøytiske formål; kapsler for medisiner; farmasøytiske preparater; kjemisk-farmasøytiske preparater; legemidler for medisinske formål; kjemiske preparater for farmasøytiske formål; biologiske preparater for medisinske formål: kjemiske preparater for medisinske formål; diagnostiske biomarkør-reagenser for medisinske formål.

Documents


Download files (3)
Date
Date Doc. No. Process Case number In/Out Journal description To/from
07.12.2020 02-01 Saksbehandling 202015475 UT Oversendelse reg. brev (VM202015475) BRYN AARFLOT AS
03.12.2020 01-02 Saksbehandling 202015475 INN Generalfullmakt VM BRYN AARFLOT AS
03.12.2020 01-01 Saksbehandling 202015475 INN Søknadsskjema Varemerke BRYN AARFLOT AS

Priority


No priority

Applicants and owners


Owners
BeiGene, Ltd.
c/o Mourant Ozannes Corporate Services, 94 Solaris Ave, Camana Bay 1-1108 GRAND CAYMAN KY

Agent


BRYN AARFLOT AS
BRYN AARFLOT AS

Org. number: 979993269

Name and address are automatically synchronized with the Brønnøysund Register Centre.

Open in The Brønnøysund Register Centre
Stortingsgata 8 0161 OSLO NO (OSLO Municipality, Oslo county)
Org. number: 979993269
Reference: 547465/TG

Status history


Payment history


Oppositions and appeals


No oppositions or appeals

Alteration of mark


No alteration of mark

Liens and licences


No liens or licenses registered

Gazette entries


No Gazette entries foundOnly events from 2024.03.04 and onwards are shown.